Evidence map›Paper›PMID 35899125›Full record

ArticleFrontiers in pharmacology2022

Peroxisomal Proliferator-Activated Receptor

Triana Espinosa-Jiménez, Oriol Busquets, Amanda Cano, Elena Sánchez-López, Ester Verdaguer, Antoni Parcerisas, Jordi Olloquequi, Carme Auladell, Jaume Folch, Walter Wahli and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 7 institutions in 5 countries.

Triana Espinosa-JiménezDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.
Oriol BusquetsDominick P. Purpura Department of Neurosciences, Albert Einstein College of Medicine, New York City, NY, United States.
Amanda CanoBiomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Elena Sánchez-LópezBiomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Ester VerdaguerBiomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Antoni ParcerisasDepartament of Basic Sciences, Universitat Internacional de Catalunya (UIC), Sant Cugat del Vallès, Spain.
Jordi OlloquequiDepartment of Biochemistry and Physiology, Faculty of Pharmacy and Food Science, University of Barcelona, Barcelona, Spain.
Carme AuladellBiomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Jaume FolchBiomedical Research Networking Centre in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.
Walter WahliCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
Manuel Vázquez-CarreraDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.
Antoni CaminsDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.
Miren EttchetoDepartment of Pharmacology, Toxicology and Therapeutic Chemistry, Faculty of Pharmacy and Food Sciences, University of Barcelona, Barcelona, Spain.
Biomedical Research Networking Center on Neurodegenerative Diseases · ESUniversitat de Barcelona · ESAlbert Einstein College of Medicine · USCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESInstitute of Advanced Chemistry of Catalonia · ESToxalim Research Centre in Food Toxicology · FRUniversitat Internacional de Catalunya · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peroxisome proliferator-activated receptor

Indexed as

dendritic spineshigh-fat dietinsulin signalingmemory impairmentneuroinflammationPPARβ/δsynapsisT2DM

Identifiers

PMID35899125
PMCPMC9310104
OpenAlexW4285029120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.